FTRE - Fortrea Holdings - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US34965K1079
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. Web URL: https://www.fortrea.com
Drawdown (Underwater) Chart
FTRE Stock Overview
Market Cap in USD | 1,917m |
Sector | Healthcare |
Industry | Biotechnology |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2023-07-03 |
FTRE Stock Ratings
Growth 5y | -67.4 |
Fundamental | -64.2 |
Dividend | 0.00 |
Rel. Performance vs Sector | -8.05 |
Analysts | 3.50/5 |
Fair Price Momentum | 15.93 USD |
Fair Price DCF | 35.39 USD |
FTRE Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
FTRE Growth Ratios
Growth 12m | -30.74% |
Growth Correlation 12m | -58% |
Growth Correlation 3m | -81% |
CAGR 5y | -30.27% |
CAGR/Mean DD 5y | -1.38 |
Sharpe Ratio 12m | -0.70 |
Alpha vs SP500 12m | -75.78 |
Beta vs SP500 5y weekly | 1.32 |
ValueRay RSI | 19.09 |
Volatility GJR Garch 1y | 46.36% |
Price / SMA 50 | -16.64% |
Price / SMA 200 | -36.61% |
Current Volume | 1078.4k |
Average Volume 20d | 2089k |
External Links for FTRE Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of FTRE stocks?
As of October 06, 2024, the stock is trading at USD 18.79 with a total of 1,078,377 shares traded.
Over the past week, the price has changed by -5.29%, over one month by -11.74%, over three months by -19.53% and over the past year by -32.89%.
As of October 06, 2024, the stock is trading at USD 18.79 with a total of 1,078,377 shares traded.
Over the past week, the price has changed by -5.29%, over one month by -11.74%, over three months by -19.53% and over the past year by -32.89%.
What are the forecast for FTRE stock price target?
According to ValueRays Forecast Model, FTRE Fortrea Holdings will be worth about 17.6 in October 2025. The stock is currently trading at 18.79. This means that the stock has a potential downside of -6.44%.
According to ValueRays Forecast Model, FTRE Fortrea Holdings will be worth about 17.6 in October 2025. The stock is currently trading at 18.79. This means that the stock has a potential downside of -6.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 24.1 | 28.3 |
Analysts Target Price | 28.7 | 52.6 |
ValueRay Target Price | 17.6 | -6.44 |